Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108373624 | 10837362 | 4 | F | 201607 | 20160920 | 20150219 | 20160922 | EXP | US-GLAXOSMITHKLINE-US2015GSK022389 | GLAXOSMITHKLINE | 64.16 | YR | F | Y | 0.00000 | 20160922 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108373624 | 10837362 | 1 | PS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | UNK, U | U | 20983 | ||||||||||
| 108373624 | 10837362 | 2 | SS | BREO ELLIPTA | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 1 PUFF(S), QD | UNKNOWN | 0 | 1 | DF | INHALATION POWDER | QD | |||||
| 108373624 | 10837362 | 3 | SS | BROVANA | ARFORMOTEROL TARTRATE | 1 | U | 0 | |||||||||||
| 108373624 | 10837362 | 4 | SS | XALATAN | LATANOPROST | 1 | Ophthalmic | 1 GTT, UNK | U | 0 | 1 | GTT | |||||||
| 108373624 | 10837362 | 5 | C | LOSARTAN. | LOSARTAN | 1 | U | 0 | |||||||||||
| 108373624 | 10837362 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 0 | |||||||||||
| 108373624 | 10837362 | 7 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | U | 0 | |||||||||||
| 108373624 | 10837362 | 8 | C | IPRATROPIUM BROMIDE + SALBUTAMOL NEBULIZER SOLUTION | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 108373624 | 10837362 | 1 | Product used for unknown indication |
| 108373624 | 10837362 | 2 | Chronic obstructive pulmonary disease |
| 108373624 | 10837362 | 3 | Product used for unknown indication |
| 108373624 | 10837362 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 108373624 | 10837362 | OT |
| 108373624 | 10837362 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 108373624 | 10837362 | Cataract operation | |
| 108373624 | 10837362 | Chronic obstructive pulmonary disease | |
| 108373624 | 10837362 | Cough | |
| 108373624 | 10837362 | Glaucoma | |
| 108373624 | 10837362 | Malaise | |
| 108373624 | 10837362 | Respiratory arrest | |
| 108373624 | 10837362 | Spinal fracture | |
| 108373624 | 10837362 | Total lung capacity decreased | |
| 108373624 | 10837362 | Upper respiratory tract infection | |
| 108373624 | 10837362 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 108373624 | 10837362 | 2 | 2015 | 0 |